Top 10 Importing Countries for Cough Suppressant & Lozenge Products Globally
Introduction:
The global market for cough suppressant and lozenge products has seen steady growth in recent years, driven by increasing awareness about respiratory health and the rise in respiratory illnesses. According to a recent report by Market Research Future, the global cough suppressant market is expected to reach USD 7.23 billion by the end of 2023. With the demand for these products on the rise, it is important to analyze the top importing countries in order to understand the key players in the market.
Top 10 Importing Countries for Cough Suppressant & Lozenge Products Globally:
1. United States – The United States is the leading importing country for cough suppressant and lozenge products globally, with an estimated market share of 30%. The high prevalence of respiratory illnesses and the presence of key market players contribute to its dominant position in the market.
2. Germany – Germany is the second largest importer of cough suppressant and lozenge products, accounting for 15% of the global market share. The country’s strong healthcare infrastructure and emphasis on OTC medications drive the demand for these products.
3. China – China is a key player in the global market, with a market share of 10%. The country’s large population and increasing disposable income are driving the demand for cough suppressant and lozenge products.
4. Japan – Japan holds a market share of 8% in the global market for cough suppressant and lozenge products. The country’s aging population and high prevalence of respiratory illnesses contribute to the steady demand for these products.
5. United Kingdom – The United Kingdom accounts for 7% of the global market share for cough suppressant and lozenge products. The country’s strong pharmaceutical industry and emphasis on self-care drive the demand for these products.
6. France – France holds a market share of 6% in the global market for cough suppressant and lozenge products. The country’s strict regulations on OTC medications ensure the quality of imported products.
7. Italy – Italy accounts for 5% of the global market share for cough suppressant and lozenge products. The country’s emphasis on natural remedies and herbal products drive the demand for these products.
8. Canada – Canada is a key player in the global market, with a market share of 4%. The country’s cold climate and high prevalence of respiratory illnesses contribute to the demand for cough suppressant and lozenge products.
9. Australia – Australia holds a market share of 3% in the global market for cough suppressant and lozenge products. The country’s strong healthcare system and emphasis on preventive care drive the demand for these products.
10. Brazil – Brazil accounts for 2% of the global market share for cough suppressant and lozenge products. The country’s large population and increasing awareness about respiratory health contribute to the demand for these products.
Insights:
The global market for cough suppressant and lozenge products is expected to continue growing in the coming years, driven by factors such as increasing respiratory illnesses and the rise in self-medication practices. According to a report by Grand View Research, the market is projected to reach USD 9.45 billion by 2025. Key players in the market are focusing on product innovation and expansion into emerging markets to capitalize on the growing demand for these products. As the importance of respiratory health continues to rise, the market for cough suppressant and lozenge products is expected to witness further growth in the future.
Related Analysis: View Previous Industry Report
